Post–EV + Pembrolizumab Treatment Advanced Urothelial Carcinoma from @drnataliagandur.bsky.social: myopenmedicine.com/algorithms/p...
Post–EV + Pembrolizumab Treatment Advanced Urothelial Carcinoma
myopenmedicine.com
Open Medicine
@openmedicine.bsky.social
Open access and free for everyone. https://myopenmedicine.com
Newly Diagnosed Multiple Myeloma: Lenalidomide Dosing by Clinical Status algorithm from Dr. Manni Mohyuddin at @huntsmancancer.bsky.social: myopenmedicine.com/algorithms/n...
Newly Diagnosed Multiple Myeloma: Lenalidomide Dosing by Clinical Status
Assuming this algorithm concerns multiple myeloma, it captures standard 25 mg treatment dosing, common renal adjustments, and a tolerability-focused approach in frail patients. Alignment is mixed beca...
myopenmedicine.com
Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma algorithm from Dr. Yelena Janjigian at MSKCC: myopenmedicine.com/algorithms/g...
Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma
Treatment algorithm for Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma by Yelena Y. Janjigian, MD, FASCO, Chief, Gastrointestinal Oncology Service at Memorial Sloan Kettering C...
myopenmedicine.com
Metastatic Colorectal Cancer: Biomarker-Driven Treatment Selection, Maintenance, and Sequencing from @drnataliagandur.bsky.social: myopenmedicine.com/algorithms/m...
Metastatic Colorectal Cancer: Biomarker-Driven Treatment Selection, Maintenance, and Sequencing
This algorithm is broadly aligned with contemporary standards for metastatic colorectal cancer, emphasizing up-front molecular profiling (MSI/MMR, extended RAS, BRAF, sidedness, HER2/rare targets), in...
myopenmedicine.com
Localized, borderline resectable and metastatic gastrointestinal stromal tumors (GISTs) from Dr. Michael Wagner at @danafarber.bsky.social: myopenmedicine.com/algorithms/l...
Localized, borderline resectable and metastatic gastrointestinal stromal tumors (GISTs)
This algorithm is broadly aligned with contemporary GIST management: upfront histologic diagnosis, mandatory KIT/PDGFRA molecular testing to guide systemic therapy, risk-adapted use of adjuvant imatin...
myopenmedicine.com
Newly Diagnosed Non-APL Acute Myeloid Leukemia: Initial Treatment Selection from @talhabadarmd.bsky.social: myopenmedicine.com/algorithms/n...
Newly Diagnosed Non-APL Acute Myeloid Leukemia: Initial Treatment Selection
This algorithm is broadly aligned with contemporary adult non-APL AML practice: urgent exclusion of APL and stabilization, early comprehensive cytogenetic/molecular profiling, fitness-based selection ...
myopenmedicine.com
Management of Platinum-Resistant and Later-Line Ovarian Cancer algorithm from @drkatymoore.bsky.social: myopenmedicine.com/algorithms/m...
Management of Platinum-Resistant and Later-Line Ovarian Cancer
myopenmedicine.com
Post–EV + Pembrolizumab Treatment Advanced Urothelial Carcinoma algorithm from @drnataliagandur.bsky.social: myopenmedicine.com/algorithms/p...
Post–EV + Pembrolizumab Treatment Advanced Urothelial Carcinoma
myopenmedicine.com
Second relapse multiple myeloma from @vincentrk.bsky.social:
Treatment of Myeloma: First Relapse from @vincentrk.bsky.social:
Comprehensive thoracic solid tumor staging and treatment options algorithm from Prof. Andrea Bille at Guy's and St Thomas' NHS Trust: myopenmedicine.com/algorithms/c...
Comprehensive thoracic solid tumor staging and treatment options
Lung cancer management based on TNM staging, where early-stage (I–II) disease is primarily treated with surgical resection (with possible adjuvant therapy), while more advanced stages (III–IV) incorpo...
myopenmedicine.com
RET fusion–positive NSCLC: evolving adjuvant and metastatic targeted therapies from Dr. Gilberto Lopes at Sylvester Cancer Center: myopenmedicine.com/algorithms/r...
RET fusion–positive NSCLC: evolving adjuvant and metastatic targeted therapies
The metastatic portion is broadly aligned with current standards: comprehensive RET fusion testing at diagnosis and first-line selective RET inhibition (selpercatinib or pralsetinib) is guideline-conc...
myopenmedicine.com
Universal Germline Genetic Testing in Prostate Cancer algorithm from Dr. Neal Shore at Atlantic Urology Clinics: myopenmedicine.com/algorithms/u...
Universal Germline Genetic Testing in Prostate Cancer
myopenmedicine.com
Low Risk and Favorable Intermediate Risk for Prostate Cancer algorithm from @tylersbrt.bsky.social: myopenmedicine.com/algorithms/l...
Low Risk and Favorable Intermediate Risk for Prostate Cancer
Selection and follow-up for men with low-risk and select favorable intermediate-risk prostate cancer. Tyler Seibert, MD, PhD, Genitourinary Section Chief at UC San Diego Radiation Oncology outlines cr...
myopenmedicine.com
Surgery for thymic tumor algorithm from Prof. Andrea Bille at Guy's and St. Thomas' NHS Foundation Trust: myopenmedicine.com/algorithms/s...
Surgery for thymic tumour
Stage-based management of thymic tumors, emphasizing complete surgical resection (via VATS/RATS or open thymectomy) for early stages, with increasing need for en bloc resection of involved structures ...
myopenmedicine.com
IBCG Risk Stratification Model for Intermediate-Risk NMIBC algorithm from Dr. Ashish Kamat: myopenmedicine.com/algorithms/i...
IBCG Risk Stratification Model for Intermediate-Risk NMIBC
Intermediate-Risk Non–Muscle-Invasive Bladder Cancer (IR NMIBC) Risk Stratification Model by the International Bladder Cancer Group (IBCG).
myopenmedicine.com
Newly Diagnosed Myeloma algorithm from @vincentrk.bsky.social: myopenmedicine.com/algorithms/n...
Newly Diagnosed Myeloma
Treatment algorithm for newly diagnosed myeloma patients. Dr. Rajkumar is a contributing editor to the International Myeloma Foundation (https://www.myeloma.org/frontline-treatment-options).Watch Dr....
myopenmedicine.com
Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma algorithm from Dr. Yelena Janjigian at @mskcancercenter.bsky.social: myopenmedicine.com/algorithms/g...
Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma
Treatment algorithm for Gastric, Gastroesophageal Junction (GEJ) and Esophageal Adenocarcinoma by Yelena Y. Janjigian, MD, FASCO, Chief, Gastrointestinal Oncology Service at Memorial Sloan Kettering C...
myopenmedicine.com
Localized and metastatic primary malignant bone sarcoma algorithm from Dr. Michael Wagner at @mdanderson.bsky.social: myopenmedicine.com/algorithms/l...
Localized and metastatic primary malignant bone sarcoma
The algorithm is broadly aligned with contemporary management of primary malignant bone sarcomas: referral to a sarcoma center, histology-driven pathways, multimodality therapy for osteosarcoma and Ew...
myopenmedicine.com
Molecular Testing for Pancreatic Cancer algorithm freom @mpishvaian.bsky.social: myopenmedicine.com/algorithms/m...
Molecular Testing for Pancreatic Cancer
Molecular testing for pancreatic cancer at first visit and within the first 2-4 weeks.
myopenmedicine.com
Metastatic Triple-Negative Breast Cancer Treatment algorithm from Dr. Samantha El Warrak at Sylvester Cancer Center: myopenmedicine.com/algorithms/m...
Metastatic Triple-Negative Breast Cancer Treatment
myopenmedicine.com
Smoldering Myeloma algorithm from @vincentrk.bsky.social: myopenmedicine.com/algorithms/s...
Smoldering Myeloma
Dr. Rajkumar's video walk through. Treatment algorithm for smoldering myeloma. Incorporates the 2025 Daratumumab FDA approval for high risk smoldering myeloma. Active drugs in multiple myeloma referen...
myopenmedicine.com
Stage I Testicular Germ Cell Tumors After Orchiectomy: Surveillance, Adjuvant Therapy, and Risk-Adapted Follow-Up algorithm from @drnataliagandur.bsky.social: myopenmedicine.com/algorithms/s...
Stage I Testicular Germ Cell Tumors After Orchiectomy: Surveillance, Adjuvant Therapy, and Risk-Adapted Follow-Up
This algorithm is broadly aligned with contemporary stage I testicular GCT management: confirm true clinical stage I with appropriate post-orchiectomy marker kinetics and imaging, then select surveill...
myopenmedicine.com
Stage I–III Non-Small Cell Lung Cancer Treatment algorithm from @janichinmay.bsky.social and Dr. Gilberto Lopes: myopenmedicine.com/algorithms/s...
Stage I–III Non-Small Cell Lung Cancer Treatment
The algorithm is broadly aligned with current management of stage I–IIIB NSCLC: guideline-concordant diagnostic workup, surgery or SBRT for early-stage disease, biomarker-driven adjuvant targeted ther...
myopenmedicine.com
Management of Platinum-Sensitive Recurrent Ovarian Cancer algorithm from @drkatymoore.bsky.social: myopenmedicine.com/algorithms/m...
Management of Platinum-Sensitive Recurrent Ovarian Cancer
The algorithm is broadly aligned with contemporary management of platinum-sensitive recurrent epithelial ovarian cancer: use of platinum-based combinations, consideration of secondary cytoreductive su...
myopenmedicine.com
Belzutifan Practical Guidance in Advanced Clear-Cell RCC algorithm from @drchoueiri.bsky.social: myopenmedicine.com/algorithms/b...
Belzutifan Practical Guidance in Advanced Clear-Cell RCC
This belzutifan-focused pathway is broadly aligned with current evidence and labeling for advanced/metastatic ccRCC after prior PD-(L)1 inhibitor and VEGF-targeted therapy, centering on LITESPARK-005 ...
myopenmedicine.com
TALAPRO-2: Talazoparib + Enzalutamide in HRR-Altered First-Line mCRPC algorithm from @neerajagarwal.bsky.social: myopenmedicine.com/algorithms/t...
TALAPRO-2: Talazoparib + Enzalutamide in HRR-Altered First-Line mCRPC
The algorithm is broadly aligned with contemporary mCRPC management: maintain ADT, perform HRR (germline/somatic) testing early, and consider PARP inhibitor combinations for HRR-altered disease. Place...
myopenmedicine.com
Early and Advanced Triple Negative Breast Cancer (TNBC) from @ilanaschlam.bsky.social: myopenmedicine.com/algorithms/e...
Early and Advanced Triple Negative Breast Cancer (TNBC)
The algorithm is broadly aligned with contemporary TNBC practice: neoadjuvant pembrolizumab plus chemotherapy for high-risk early TNBC; adjuvant escalation strategies for residual disease including ca...
myopenmedicine.com